Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Diagnostic Microbiology and Infectious Disease

Volumn 77, Issue 1, 2013, Pages 37-40

  Pfaller, Michael A ^a   Diekema, Daniel J ^a   Procop, Gary W ^b   Rinaldi, Michael G ^c  

^a UNIVERSITY OF IOWA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Candida; CLSI; Susceptibility test; Vitek 2

Indexed keywords

FLUCONAZOLE; VORICONAZOLE;

ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA ANOMALA; PICHIA GUILLIERMONDII; PRIORITY JOURNAL; STRAIN DIFFERENCE; WILD TYPE;

EID: 84881548311     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.05.019     Document Type: Article

References (21)

1. Borghi E., Iatta R., Sciota R., et al. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study. J Clin Microbiol 2010, 48:3153-3157.
2. Bourgeois N., Dehandschoewercker L., Beitout S., et al. Antifungal susceptibility of 205 Candida spp. isolated primarily during invasive candidiasis and comparison of the Vitek 2 system with the CLSI broth microdilution and Etest methods. J Clin Microbiol 2010, 48:154-161.
3. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard - 3rd edition, M27-A3 2008, CLSI, Wayne, PA.
4. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd informational supplement (M27-S3) 2008, CLSI, Wayne, PA.
5. Cuenca-Estrella M., Gomez-Lopez A., Alastruey-Izquierdo A., et al. Comparison of trfaut Clinical andhe Vitek 2 antifungal susceptibility system with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre Yeast One and Etest techniques for in vitro detection of antifungal resistances in yeast isolates. J Clin Microbiol 2010, 48:1782-1786.
6. Hazen K.C., Howell S.A. Candida, Cryptococcus and other yeasts of medical importance. Manual of Clinical Microbiology 2003, 1693-1711. ASM Press, Washington DC. 8th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
7. National Committee for Clinical Laboratory Standards (NCCLS) Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 2nd ed, M27-A2 2002, NCCLS, Wayne, PA.
8. Pfaller M.A., Diekema D.J., Sheehan D.J. Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing. Clin Microbiol Rev 2006, 19:435-447.
9. Pfaller M.A., Diekema D.J., Rex R.H., et al. Correlation of MIC with outcome for Candida species against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol 2006, 44:819-826.
10. Pfaller M.A., Diekema D.J., Procop G.W., Rinaldi M.G. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J Clin Microbiol 2007, 45:796-802.
11. Pfaller M.A., Diekema D.J., Procop G.W., Rinaldi M.G. Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp. J Clin Microbiol 2007, 45:3522-3528.
12. Pfaller M.A., et al. Validation of 24-hour fluconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: results from a global Candida antifungal surveillance program. J Clin Microbiol 2008, 46:3585-3590.
13. Pfaller M.A., et al. Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods. Drug Resist Update 2010, 13:180-195.
14. Pfaller M.A., Diekema D.J. Wild-type MIC distributions and epidemiologic cutoff values for fluconazole and Candida: time for new clinical breakpoints?. Curr Fungal Infect Rep 2010, 4:168-174.
15. Pfaller M.A., et al. Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program. J Clin Microbiol 2011, 49:1274-1279.
16. Pfaller M.A., et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiological, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis 2011, 70:330-343.
17. Pfaller M.A., et al. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. J Clin Microbiol 2011, 49:630-637.
18. Pfaller M.A., et al. Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. J Clin Microbiol 2011, 49:3800-3804.
19. Pfaller M.A., Diekema D.J. Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012. J Clin Microbiol 2012, 50:2846-2856.
20. Posteraro B., Martucci R., La Sorda M., et al. Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata. J Clin Microbiol 2009, 47:1927-1930.
21. Shah D.N., Yau R., Weston J., et al. Evaluation of antifungal therapy in patients with candidemia based on susceptibility testing results: implications for antimicrobial stewardship programs. J Antimicrob Chemother 2011, 66:2146-2151.